Category: Prescription Drugs
United States Prescription Drugs
-
US Urinary Tract Infection Therapeutics outlook to 2028
... a huge problem in the US. US typically see more than 8 million cases of UTIs every year. According to Ken Research, the US Urinary Tract Infection (UTI) Therapeutics market is anticipated to grow at ... Read More
-
United States Pain Management Therapeutics Market, Forecast 2023-2030, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis
... Research. Physical and mental pain has a significant influence on life. It can hinder our daily activities, limit our mobility, and dampen our spirits. Advancements in medical technology and growing awareness have opened up new ... Read More
-
Out of Pocket Spending in Healthcare (Pharmaceuticals, Surgeries, Tests, Electives, Premiums, Copays, Doctor Visits, Other), 6th Edition
... United States. Out-of-Pocket Healthcare Expenditures in the United States, 6th Edition examines these trends in detail, focusing on the financial aspects of OOP spending growth and quantifying the growth of OOP spending with forecasts of ... Read More
-
Pet Medications: United States
... the retail market for medications for domestic dogs and cats, with a focus on products purchased directly by consumers. These include prescription, over-the-counter (also called OTC or retail), and nonprescription medications that are only distributed ... Read More
-
Global HIV Treatment Market: Analysis By Product (Atripla, Biktarvy, Descovy, Genovya, Odefsey, Truvada, Sunlenca (Lenacapavir), Dovato, Juluca, Tivicay, Triumeq, Cabenuva, VH184, Capsid, bNAbs, Islatravir, and Generics), By Region (The US, and EU + ROW) Size and Trends with Impact of COVID-19 and Forecast up to 2030
... and Trends with Impact of COVID-19 and Forecast up to 2030 The global HIV treatment market in 2022 stood at US$22.38 billion, and is likely to reach US$25.49 billion by 2030. HIV treatment, also known ... Read More
-
Pet Medications in the US, 8th Edition
... Price Index (CPI) was up 9.2% for pets/pet products, according to the US Bureau of Labor Statistics (BLS). For the pet medications market, 2020 and 2021 were boom years, but the market’s lackluster 3.7% growth ... Read More
-
US Pharma Packaging Market - Focused Insights 2023-2028
... materials and products are included in the report. Revenue generated by service providers are excluded from the scope of the report. This report provides a comprehensive and current market scenario of the US pharmaceutical packaging, ... Read More
-
United States Pharmaceutical Logistics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... Highlights Transportation problems were making it hard to distribute COVID-19, which was causing problems in the drug supply chain.Port disruptions, quarantined personnel, and labor shortages caused by lockdowns were all factors. Furthermore, COVID-19 slowed the ... Read More
-
U.S. Dietary Supplements Market Size, Share & Trends Analysis Report By Type (OTC, Prescribed), By Ingredient, By Form, By Application, By End-user, By Distribution Channel, And Segment Forecasts, 2023 - 2030
... Growth & Trends The U.S. dietary supplements market size is expected to reach USD 78.94 billion by 2030, registering a CAGR of 5.7% from 2023 to 2030, according to a new report by Grand View ... Read More
-
The U.S. Medical Weight Loss Market
... greater focus on medical weight loss programs using the new obesity drugs. The big story of 2022 has been the soaring demand for new obesity drugs such as Wegovy, Ozempic and Saxenda, with more new ... Read More
-
US Electric Bus Market 2022-2028
... in the country is among the key factors to drive the growth of the electric bus market in the US. The US Federal Transit Administration (FTA) had offered several grants for the purchase of electric ... Read More
-
The U.S. Weight Loss & Diet Control Market
... Covid-19 pandemic and recession. The big story of 2022 has been the soaring demand for new obesity drugs such as Wegovy and Saxenda, with more new drugs coming soon. The market may be entering a ... Read More
-
Contract Research Organizations in the US - Industry Market Research Report
... for Food and Drug Administration (FDA) approval. An explosion in research and development investment, frustratingly high clinical trial costs and an uptick in patent expirations have driven pharmaceutical companies to outsource clinical trial management. These ... Read More
-
United States Diabetes Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis
... United States, Diabetes is the 7th leading cause of death. Diabetes is a persistent disease that happens either when the pancreas has not produced enough insulin or when the body cannot effectively and efficiently uses ... Read More
-
U.S. Diabetic Neuropathy Market, by Drug (Tricyclic Antidepressants (Amitriptyline, Nortyptyline, Imipramine, Desipramine), SSRI (Paroxetine, Citalopram), Anticonvulsants (Gabapentin, Pregabalin, Carbamazepine), Opioids (Tramadol, Tapentadol, Oksikodon), SNRIs (Duloxetine), Other Drugs (Capsaicin, Lidocaine, Botilinum Toxin)) by Type (Peripheral Neuropathy, Proximal Neuropathy, Autonomic Neuropathy, Focal Neuropathy), by Route of Administration (Oral, Topical, Injection (Intramuscular)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Proximal Neuropathy, Autonomic Neuropathy, Focal Neuropathy), by Route of Administration (Oral, Topical, Injection (Intramuscular)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Diabetic neuropathy is ... Read More
-
UNITED STATES INSULIN DRUGS AND DELIVERY DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... than 2.5% over the forecast period. Since the start of the epidemic, the United States has recorded 79 million cases of COVID-19. Over 960,000 people have died in the United States because of COVID-19. The ... Read More
-
United States Healthcare Fraud Detection Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... COVID-19 epidemic illustrates how public health crises affect emergency departments and hospital systems. The pandemic of COVID-19 had a tremendous impact on healthcare delivery. Urgent adjustments in billing codes, telehealth, and prescriptions enabled health care ... Read More
-
The U.S. Autism Treatment Centers Market
... provided by therapists. There are waiting lists, significant untapped demand, and private equity investors are backing new ventures. Franchises are emerging. The incidence of autism among American children has soared from 1 in 150 in ... Read More
-
Epilepsy Medication Manufacturing in the US - Industry Market Research Report
... report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players ... Read More
-
North America Osteoporosis Treatment Market, By Drug Class (Bisphosphonate, Hormone Replacement Therapy, Selective Estrogen Receptor Modulator, Rank Ligand Inhibitor and Others), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others), By Country (U.S. and Canada), Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... Pharmacies and Others), By Country (U.S. and Canada), Trend Analysis, Competitive Market Share & Forecast, 2018-2028 North America Osteoporosis Treatment Market to Cross USD 10.25 Billion by 2028 North America Osteoporosis Treatment Market is growing ... Read More
-
U.S. Opioids Market, by Drugs (Codeine, Fentanyl, Meperidine, Methadone, Morphine, and Hydrocodone), by Therapeutic Application (Pain Management (Neuropathic Pain, Migraine, Back Pain, Osteoarthritis Pain, Cancer Pain, and Others), Cough Treatment, and Diarrhea Treatment), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Opioids can be defined as a class of drugs, which include the drug heroin, synthetic opioids ... Read More
-
U.S. Behavioral Health Care Software And Services Market Size, Share & Trends Analysis Report By Component (Software, Support Services), By Delivery Model, By Function, By End Use, And Segment Forecasts, 2022 - 2030
... by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.12% from 2022 to 2030. An increase in the adoption of technological solutions for the management of clinical, administrative, and ... Read More
-
Controlled Substance Market (Product Type: Opioids, Stimulants, Depressants, and Cannabinoids) - U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... controlled substance market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report ... Read More
-
U.S. Degenerative Disc Disease Treatment Market, by Treatment (Epidural Steroid Injections, Narcotics (Morphine, Methadone Hydrochloride, Codeine, Hydrocodone, Tramodol, Oxycodone, and Others), Orthobiologics (Includes Biomolecular/Gene Therapy, Cell-base
... Phase III), by Disease Indication (Early Stage, Mid Stage, and Late Stage), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Degenerative disc ... Read More
-
U.S. Injectable Compounding Pharmacy Market, by Molecule (Acetaminophen, Phenylephrine, Midazolam, Esmolol, Vancomycin, Epinephrine, Adenocaine, Fentanyl / Bupivacaine, Morphine, Amiodarone, Fentanyl, Heparin, Ketamine, Dextrose, Hydromorphone, Bupivacain
... (Ropivacaine, Ketorolac, Ketamine), Norepinephrine, Diltiazem, Vasopressin, and Others), by Packaging Type (Vials, Ampoules, Prefilled Syringes, and Others), and by Pharmacy Type (503A Pharmacies and 503B Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2022 - ... Read More
Research Assistance
